There are many treatments available for MS, many of which can help decrease the frequency and severity of relapses, improve physical function, and ease symptoms caused by the condition.
The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...
Cosmos Health (COSM) announced the filing of a patent application for treatment for multiple sclerosis, a disabling autoimmune disorder ...
According to Grand View Research, the global multiple sclerosis treatment market has been experiencing steady growth, driven by advancements in therapeutic options and a rising prevalence of the ...
Therefore, professionals usually reserve this treatment for cases where other multiple sclerosis treatment options, such as oral medications or physical therapy, have been ineffective. It is ...
Mothers with multiple sclerosis had an elevated incidence and prevalence of peripartum mental illness vs. mothers without MS ...
Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...
1d
News Medical on MSNProfessor Jeannette Lechner-Scott wins 2024 MS Research AwardScott, an internationally recognized neurologist and leader in multiple sclerosis (MS) research and clinical care, has been awarded the 2024 MS Research Award by MS Australia.
Recent research highlights a concerning trend: pregnant people with multiple sclerosis are more prone to mental illnesses ...
A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results